REMERONSOLTAB is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Organon Usa Inc.. The primary component is Mirtazapine.
Product ID | 0052-0110_1594f744-89b7-488d-bf1b-516340e924f9 |
NDC | 0052-0110 |
Product Type | Human Prescription Drug |
Proprietary Name | REMERONSOLTAB |
Generic Name | Mirtazapine |
Dosage Form | Tablet, Orally Disintegrating |
Route of Administration | ORAL |
Marketing Start Date | 2001-01-12 |
Marketing Category | NDA / NDA |
Application Number | NDA021208 |
Labeler Name | Organon USA Inc. |
Substance Name | MIRTAZAPINE |
Active Ingredient Strength | 45 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2001-01-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021208 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2001-01-12 |
Marketing Category | NDA |
Application Number | NDA021208 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2001-01-12 |
Ingredient | Strength |
---|---|
MIRTAZAPINE | 45 mg/1 |
SPL SET ID: | 31f48378-27db-424f-a4c5-82584a553c35 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0052-0106 | REMERONSOLTAB | MIRTAZAPINE |
0052-0108 | REMERONSOLTAB | MIRTAZAPINE |
0052-0110 | REMERONSOLTAB | MIRTAZAPINE |
0093-7206 | Mirtazapine | Mirtazapine |
0093-7207 | Mirtazapine | Mirtazapine |
0093-7208 | Mirtazapine | Mirtazapine |
0115-1653 | Mirtazapine | Mirtazapine |
0115-1654 | Mirtazapine | Mirtazapine |
0115-1656 | Mirtazapine | Mirtazapine |
0185-0020 | mirtazapine | mirtazapine |
0052-0105 | REMERON | MIRTAZAPINE |
0052-0107 | REMERON | MIRTAZAPINE |
0052-0109 | REMERON | MIRTAZAPINE |
0052-4364 | REMERON | MIRTAZAPINE |
0052-4365 | REMERON | MIRTAZAPINE |